Edegem, Belgium

Jean-Paul R Bosmans


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Kortrijk-Marke, BE (1993 - 1997)
  • Edegem, BE (1995 - 1999)
  • Rijkevorsel, BE (1999 - 2000)

Company Filing History:


Years Active: 1993-2000

Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Paul R Bosmans

Introduction

Jean-Paul R Bosmans, based in Edegem, Belgium, is a notable inventor with a substantial portfolio of innovations, holding 21 patents to his name. His work primarily focuses on pharmaceutical developments that have significant implications in the field of medicine.

Latest Patents

Among his latest patents are two noteworthy inventions: "2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonist" and "Esters of 3-hydroxy-piperidinemethanol derivatives." These contributions reflect his dedication to advancing therapeutic options for various medical conditions.

Career Highlights

Jean-Paul has had an impressive career at prestigious organizations. He has worked with Janssen Pharmaceutica NV and Tanssen Pharmaceutica NV, companies renowned for their cutting-edge research and development in pharmaceuticals. His work in these environments has greatly shaped his innovative capabilities and offerings.

Collaborations

Collaboration has been a significant aspect of Jean-Paul's career. Notable colleagues such as Georges H Van Daele and Paul A Janssen have worked alongside him, contributing to a synergistic environment that fosters impactful pharmaceutical advancements.

Conclusion

Jean-Paul R Bosmans exemplifies the essence of innovation and collaboration within the pharmaceutical industry. His extensive patent portfolio and collaborations highlight his critical role in shaping medical treatments and advancing healthcare solutions. His work continues to inspire future inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…